How Can Stem Cells Help COPD?

Chronic Obstructive Pulmonary Disease (COPD) is a debilitating lung disease, meaning that it worsens over time without proper treatment and symptom management. The progression of the disease goes through four stages, from mild to very severe. It is characterized by a restriction of airflow into and out of the lungs that makes breathing difficult. COPD is the umbrella term for sufferers who have been diagnosed with or show signs of emphysema and/or chronic bronchitisStem Cell Therapy for COPD is emerging as a practical option for people suffering from this condition.

Therapy for COPD 

Unfortunately, there isn’t a known cure for COPD, but that does not mean that the disease can’t be treated. Many physicians prescribe bronchodilators to help expand the airways, allowing more air to enter and exit the lungs. Also, it is common that a COPD treatment program to include a regiment of breathing and aerobic exercise to rehabilitate some pulmonary functioning. For people in the most severe stages of COPD, supplemental oxygen is also used for treatment. Although most of these treatments are helpful, they do not assistance in the reversal of any symptoms, they are simply used to slow the progression of the disease. A group of physicians have discovered over the past decade that the use of stem cells can have a positive effect in treating COPD and other pulmonary conditions.

What are Stem Cells? 

Stem cells are the foundational blocks for any type of living organism. They have the capability for self-renewal and duplication, able to form any type of tissue or organ in your body. Adult stem cells from one organ are capable of creating tissue for another organ, which is called plasticity. It has been established that adult stem cells are able to be transferred into any one single organ in your body.

Stem Cell Therapy for COPD 

In the case of therapy for lung diseases, autologous stem cells are used, meaning they originate from the patient’s own body, and can be found in blood and bone marrow tissue. Stem cells have the capability to form many types of different cells. During the procedure, stem cell therapy involves separating adult stem cells, which requires specialized laboratory equipment to harvest them. After being removed from the patient’s body, they are then processed and isolated. They are then delivered to the patient intravenously. It surprises many people to hear that the therapy is minimally invasive and usually an outpatient procedure. These medical procedures should be conducted in a clinical venue under the supervision of a trained physician. It takes a professional that has sought specific training in stem cell therapy to perform the treatment safely and proficiently. If you would like to speak with someone to find out if you qualify for stem cell therapy for COPD, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.